Literature DB >> 7762049

Treadmill training with partial body weight support compared with physiotherapy in nonambulatory hemiparetic patients.

S Hesse1, C Bertelt, M T Jahnke, A Schaffrin, P Baake, M Malezic, K H Mauritz.   

Abstract

BACKGROUND AND
PURPOSE: Treadmill training with partial body weight support is a new and promising therapy in gait rehabilitation of stroke patients. The study intended to investigate its efficiency compared with gait training within regular physiotherapy in nonambulatory patients with chronic hemiparesis.
METHODS: An A-B-A single-case study design compared treadmill training plus partial body weight support (A) with physiotherapy based on the Bobath concept (B) in seven nonambulatory hemiparetic patients. The minimum poststroke interval was 3 months, and each treatment phase lasted 3 weeks. Variables were gait ability assessed by the Functional Ambulation Category, other motor functions tested by the Rivermead Motor Assessment, muscle strength assessed by the Motricity Index, muscle tone rated by the Modified Ashworth Spasticity Scale, and gait cycle parameters.
RESULTS: Treadmill training was more effective with regard to restoration of gait ability (P < .05) and walking velocity (P < .05). Other motor functions improved steadily during the study. Muscle strength did not change, and muscle tone varied in an unsystematic way. The ratio of cadence to stride length did not alter significantly.
CONCLUSIONS: Treadmill training offers the advantages of task-oriented training with numerous repetitions of a supervised gait pattern. It proved powerful in gait restoration of nonambulatory patients with chronic hemiparesis. Treadmill training could therefore become an adjunctive tool to regain walking ability in a shorter period of time.

Entities:  

Mesh:

Year:  1995        PMID: 7762049     DOI: 10.1161/01.str.26.6.976

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  78 in total

Review 1.  Body weight-supported treadmill training after stroke.

Authors:  S Hesse; C Werner; A Bardeleben; H Barbeau
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

Review 2.  Constraint-induced movement therapy to enhance recovery after stroke.

Authors:  E Taub; D M Morris
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

Review 3.  Understanding stroke recovery and rehabilitation: current and emerging approaches.

Authors:  Mary L Dombovy
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

Review 4.  Strategies for stroke rehabilitation.

Authors:  Bruce H Dobkin
Journal:  Lancet Neurol       Date:  2004-09       Impact factor: 44.182

5.  Effect of body weight support on cortical activation during gait in patients with stroke.

Authors:  Ichiro Miyai; Mitsuo Suzuki; Megumi Hatakenaka; Kisou Kubota
Journal:  Exp Brain Res       Date:  2005-10-20       Impact factor: 1.972

6.  Recumbent stepping has similar but simpler neural control compared to walking.

Authors:  Rebecca H Stoloff; E Paul Zehr; Daniel P Ferris
Journal:  Exp Brain Res       Date:  2006-10-27       Impact factor: 1.972

7.  Improving poststroke recovery: neuroplasticity and task-oriented training.

Authors:  Richard L Harvey
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-06

Review 8.  Neurorobotic and hybrid management of lower limb motor disorders: a review.

Authors:  Juan C Moreno; Antonio J Del Ama; Ana de Los Reyes-Guzmán; Angel Gil-Agudo; Ramón Ceres; José L Pons
Journal:  Med Biol Eng Comput       Date:  2011-08-17       Impact factor: 2.602

Review 9.  Treadmill training for the treatment of gait disturbances in people with Parkinson's disease: a mini-review.

Authors:  T Herman; N Giladi; J M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

Review 10.  Poststroke motor dysfunction and spasticity: novel pharmacological and physical treatment strategies.

Authors:  Stefan Hesse; Cordula Werner
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.